Free. Unsubscribe any time.
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 37 transactions and 186,812 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-09, came on the same day as the one before it (2026-09-09) and reports 4 transactions against 2 in the filing before it.
- The sales it reports total 13,953 shares, 3,953 more than the 10,000 in the filing before it.
- Its 19 plan statements rank 296th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 19 filings on file run from 2025-03-26 to 2026-09-09, and state 8 plan adoption dates, from 2024-12-12 to 2026-05-29.
Trades in Tarsus Pharmaceuticals, Inc. 37
- Azamian Bobak R. — 2025-03-24 · S · 6,000 shares
- Mottiwala Aziz — 2025-06-09 · S · 17,500 shares
- Azamian Bobak R. — 2025-08-11 · S · 6,000 shares
- Azamian Bobak R. — 2025-09-24 · S · 6,000 shares
- LINK WILLIAM J PHD — 2025-12-15 · S · 5,046 shares
- LINK WILLIAM J PHD — 2025-12-15 · S · 6,306 shares
- LINK WILLIAM J PHD — 2025-12-15 · S · 1,148 shares
- LINK WILLIAM J PHD — 2025-12-15 · S · 5,680 shares
- LINK WILLIAM J PHD — 2025-12-15 · S · 4,766 shares
- Whitfield Dianne C. — 2025-12-16 · S · 7,397 shares
- Azamian Bobak R. — 2025-12-24 · S · 5,443 shares
- Azamian Bobak R. — 2025-12-24 · S · 557 shares
Adoption dates in Tarsus Pharmaceuticals, Inc. 8
- 2024-12-12 — stated in 4 filings
- 2025-03-10 — stated in 1 filing
- 2025-09-08 — stated in 3 filings
- 2025-09-12 — stated in 2 filings
- 2025-11-13 — stated in 3 filings
- 2025-12-09 — stated in 3 filings
- 2026-02-27 — stated in 1 filing
- 2026-05-29 — stated in 2 filings
Results prints in Tarsus Pharmaceuticals, Inc. 7
- 2025-02-25
- 2025-05-01
- 2025-08-06
- 2025-11-04
- 2026-02-23
- 2026-05-06
- 2026-08-06
Trades before a print in Tarsus Pharmaceuticals, Inc. 0
- 38 days before the 2025-05-01 print — 2025-03-24 · S · Azamian Bobak R. · 6,000 shares
- 41 days before the 2025-11-04 print — 2025-09-24 · S · Azamian Bobak R. · 6,000 shares
- 47 days before the 2026-05-06 print — 2026-03-20 · S · Neervannan Seshadri · 2,989 shares
- 50 days before the 2026-08-06 print — 2026-06-17 · S · Azamian Bobak R. · 4,582 shares
- 50 days before the 2026-08-06 print — 2026-06-17 · S · Azamian Bobak R. · 5,418 shares
- 51 days before the 2026-05-06 print — 2026-03-16 · S · LINK WILLIAM J PHD · 3,629 shares
- 51 days before the 2026-05-06 print — 2026-03-16 · S · LINK WILLIAM J PHD · 8,378 shares
- 51 days before the 2026-05-06 print — 2026-03-16 · S · LINK WILLIAM J PHD · 493 shares
- 52 days before the 2026-02-23 print — 2026-01-02 · S · Whitfield Dianne C. · 5,715 shares
- 52 days before the 2026-02-23 print — 2026-01-02 · S · Whitfield Dianne C. · 8,122 shares
- 52 days before the 2026-02-23 print — 2026-01-02 · S · Whitfield Dianne C. · 835 shares
- 52 days before the 2026-02-23 print — 2026-01-02 · S · Whitfield Dianne C. · 893 shares
Interval to Tarsus Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 38shortest, days
- 11no later print
Adoption dates Tarsus Pharmaceuticals, Inc. states
- 2024-12-12 in 4 filings
- 2025-03-10 in 1 filing
- 2025-09-08 in 3 filings
- 2025-09-12 in 2 filings
- 2025-11-13 in 3 filings
- 2025-12-09 in 3 filings
- 2026-02-27 in 1 filing
- 2026-05-29 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 8, 2025”
Reported results dates on file
- 2025-02-25
- 2025-05-01
- 2025-08-06
- 2025-11-04
- 2026-02-23
- 2026-05-06
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.